EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62000CJ0127
Judgment of the Court (Sixth Chamber) of 11 December 2003. # Hässle AB v Ratiopharm GmbH. # Reference for a preliminary ruling: Bundesgerichtshof - Germany. # Council Regulation (EEC) No 1768/92 - Medicinal products - Supplementary protection certificate - Articles 15 and 19 - Validity of Article 19 - Concept of first authorisation to place ... on the market in the Community - Legal effects of non-compliance with the relevant date referred to in Article 19. # Case C-127/00.
Rozsudok Súdneho dvora (šiesta komora) z 11. decembra 2003.
Hässle AB proti Ratiopharm GmbH.
Návrh na začatie prejudiciálneho konania Bundesgerichtshof - Nemecko.
Vec C-127/00.
Rozsudok Súdneho dvora (šiesta komora) z 11. decembra 2003.
Hässle AB proti Ratiopharm GmbH.
Návrh na začatie prejudiciálneho konania Bundesgerichtshof - Nemecko.
Vec C-127/00.
ECLI identifier: ECLI:EU:C:2003:661
«(Council Regulation (EEC) No 1768/92 – Medicinal products – Supplementary protection certificate – Articles 15 and 19 – Validity of Article 19 – First authorisation to place ... on the market ... in the Community – Legal effects of non-compliance with the reference date referred to in Article 19)»
|
I - 0000 | |||
|
I - 0000 | |||
(Council Regulation No 1768/92, Art. 19)
(Council Regulation No 1768/92, Art. 19)
(Council Regulation No 1768/92, Arts 15 and 19)
JUDGMENT OF THE COURT (Sixth Chamber)
11 December 2003 (1)
((Council Regulation (EEC) No 1768/92 – Medicinal products – Supplementary protection certificate – Articles 15 and 19 – Validity of Article 19 – Concept of first authorisation to place ... on the market in the Community – Legal effects of non-compliance with the relevant date referred to in Article 19))
In Case C-127/00, REFERENCE to the Court under Article 234 EC by the Bundesgerichtshof (Germany) for a preliminary ruling in the proceedings pending before that court between Hässle ABand
Ratiopharm GmbH, on the interpretation of Articles 15 and 19 of Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products (OJ 1992 L 182, p. 1),THE COURT (Sixth Chamber),,
after considering the written observations submitted on behalf of:
having regard to the Report for the Hearing,
after hearing the oral observations of Hässle AB, Ratiopharm GmbH, the Danish Government and the Commission at the hearing on 8 November 2001,
after hearing the Opinion of the Advocate General at the sitting on 26 February 2002,
gives the following
On those grounds,
THE COURT (Sixth Chamber),
in answer to the questions referred to it by the Bundesgerichtshof by order of 1 February 2000, hereby rules:
Skouris |
Gulmann |
Cunha Rodrigues |
Schintgen |
Macken |
|
R. Grass |
V. Skouris |
Registrar |
President |